Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Milan - Delayed Quote EUR

Bayer Aktiengesellschaft (1BAYN.MI)

23.00
+0.46
+(2.04%)
At close: 5:35:29 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. William N. Anderson Chairman of the Management Board & CEO 5.24M -- 1966
Mr. Wolfgang U. Nickl CFO & Member of Management Board 2.14M -- 1969
Mr. Stefan Oelrich Head of the Pharmaceuticals Division & Member of the Board of Management 2.19M -- 1968
Mr. Rodrigo Santos Member of Management Board & President of the Crop Science Division 2.28M -- 1973
Ms. Heike Prinz Chief Talent Officer, Labor Director & Member of Management Board 2.3M -- 1964
Mr. Julio Triana Member of Management Board & President of Consumer Health Division 2.09M -- 1965
Dr. Sebastian Guth Ph.D. Chief Operating Officer -- -- --
Amanda McClerren Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division -- -- --
Dr. Jost Reinhard Head of Investor Relations -- -- 1972
Dr. Thomas Laubert Head of Law, Patents & Compliance -- -- 1973

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
49 214 30 1 https://www.bayer.com
Sector: 
Healthcare
Full Time Employees: 
90,587

Description

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Corporate Governance

Bayer Aktiengesellschaft’s ISS Governance QualityScore as of April 1, 2025 is 3. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 1; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

May 13, 2025 at 5:30 AM UTC

Bayer Aktiengesellschaft Earnings Date

Recent Events

Related Tickers